TPM1 and urinary bladder cancer: Additionally, integrating multi-omics analyses may reveal broader regulatory networks involving miR-183-5p and TPM1, and investigating combinatorial biomarker panels could enhance diagnostic precision, risk stratification, and therapeutic monitoring in bladder cancer.